
In rare diseases, the “magic” lies in close collaboration between individual investigators at academic institutions, the pharmaceutical industry, and funding institutions such as the National Cancer Institute.

Your AI-Trained Oncology Knowledge Connection!


Published: April 17th 2012 | Updated: